Merck Licenses Bend’s Research Technology

Bend Research has entered into a licensing agreement with Merck, under which Bend Research will provide Merck access to its spray-dried dispersion (SDD) technology. If needed, Bend may also provide Merck with access to additional drug-delivery platforms and intellectual property, including modified-release technologies and drug-discovery formulation tools.

The two companies will use their scientific and engineering capabilities in an effort to solve complex formulation and process-development problems, with the goal of transferring these solutions to a cGMP environment.

“We are excited to extend our working relationship with Merck,” said Rod Ray, chief executive officer of Bend Research. “Building stronger collaborative relationships with leading companies like Merck is important to Bend Research’s future. This relationship expands our opportunities to deliver best-in-class medicines and fits well with Merck’s mission to help provide innovative products that save and improve people’s lives.”